Mortality surrogates in combined pulmonary fibrosis and emphysemaEUROPEAN RESPIRATORY JOURNALIF212023-11-161OAAI
Results of microbiome analyses on bronchoalveolar lavage (BAL) sampleEUROPEAN RESPIRATORY JOURNALIF212023-10-270PRE
Temporal progression of mediastinal lymphadenopathy in idiopathic pulmonary fibrosisEUROPEAN RESPIRATORY JOURNALIF212022-02-030OAAI
Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: Survival analysis using visual and computer-based computed tomography assessmentECLINICALMEDICINEIF102021-08-019OAAI
New Perspectives on Difficult Asthma; Sex and Age of Asthma-Onset Based Phenotypes困难哮喘的新观点; 基于哮喘发作表型的性别和年龄JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62020-11-0127OAAI
A review of patients following a diagnosis of unclassified interstitial lung disease (ILD) at a tertiary centreEUROPEAN RESPIRATORY JOURNALIF212020-10-280PRE
Feasibility of a cardiopulmonary exercise test ( CPET) derived high-intensity interval training programme (HIIT) in idiopathic pulmonary fibrosis (IPF)EUROPEAN RESPIRATORY JOURNALIF212020-10-280PRE
What proportion of patients with Idiopathic Pulmonary Fibrosis fall outside UK prescribing criteria for anti-fibrotic treatment? A UK specialist centre reviewEUROPEAN RESPIRATORY JOURNALIF212019-11-210PRE
Temporal changes in mediastinal lymphadenopathy in patients with idiopathic pulmonary fibrosisEUROPEAN RESPIRATORY JOURNALIF212019-11-210PRE